Qol Holdings Management

Management Kriterienprüfungen 2/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

Takashi Nakamura

Geschäftsführender

n/a

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	n/a
Amtszeit als Geschäftsführer	17.3yrs
Eigentum des Geschäftsführers	4.4%
Durchschnittliche Amtszeit des Managements	10.4yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder	9.8yrs

Jüngste Management Updates

Recent updates

Geschäftsführer

Takashi Nakamura (54 yo)

17.3yrs

Amtszeit

Mr. Takashi Nakamura serves as President at Qol Holdings Co., Ltd. And also served as its Chief Operating Officer until October 01, 2020 and served as its Vice President since June 2007. Mr. Nakamura has b...

Führungsteam

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Takashi Nakamura	President & Representative Director	no data	keine Daten	4.39% ¥ 2.3b
Kazumi Kudo	Executive Officer and Head of General Affairs & Legal Affairs	no data	keine Daten	keine Daten
Shinichiro Abe	Senior Executive Officer & GM of Public Relations Division	no data	keine Daten	keine Daten
Yutaka Togashi	Chief of Human Resources Headquarters & Executive Director	3.9yrs	keine Daten	0.064% ¥ 34.4m
Kiyonobu Fukumitsu	Representative	11.4yrs	keine Daten	0.17% ¥ 90.6m
Mitsuo Imura	MD & GM of Development Division	12.4yrs	keine Daten	keine Daten
Yukari Onchi	GM of Education Promoting Dept. & Executive Director	10.4yrs	keine Daten	0.090% ¥ 48.0m
Isao Araki	Director & Chief of Pharmacy Business Management Headquarters	no data	keine Daten	keine Daten
Takayoshi Ishii	Chief of Corporate Strategy Headquarters	3.9yrs	keine Daten	0.040% ¥ 21.3m
Chie Hashimoto	Audit & Supervisory Board Member	no data	keine Daten	keine Daten

10.4yrs

Durchschnittliche Betriebszugehörigkeit

58yo

Durchschnittliches Alter

Erfahrenes Management: 3034Das Führungsteam des Unternehmens verfügt über eine langjährige Erfahrung (10.2 ).

Vorstandsmitglieder

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Takashi Nakamura	President & Representative Director	17.3yrs	keine Daten	4.39% ¥ 2.3b
Yutaka Togashi	Chief of Human Resources Headquarters & Executive Director	3.9yrs	keine Daten	0.064% ¥ 34.4m
Kiyonobu Fukumitsu	Representative	15.3yrs	keine Daten	0.17% ¥ 90.6m
Mitsuo Imura	MD & GM of Development Division	13.3yrs	keine Daten	keine Daten
Yukari Onchi	GM of Education Promoting Dept. & Executive Director	10.3yrs	keine Daten	0.090% ¥ 48.0m
Isao Araki	Director & Chief of Pharmacy Business Management Headquarters	no data	keine Daten	keine Daten
Takayoshi Ishii	Chief of Corporate Strategy Headquarters	no data	keine Daten	0.040% ¥ 21.3m
Chie Hashimoto	Audit & Supervisory Board Member	3.9yrs	keine Daten	keine Daten
Masaru Nakamura	Chairman of the Board	31.9yrs	keine Daten	0.73% ¥ 388.0m
Shinobu Karasawa	Director	2.3yrs	keine Daten	keine Daten
Katsuo Amioka	Independent External Director	9.3yrs	keine Daten	keine Daten
Toshiko Kuboki	Independent Outside Director	9.3yrs	keine Daten	0.0080% ¥ 4.3m

9.8yrs

Durchschnittliche Betriebszugehörigkeit

63yo

Durchschnittliches Alter

Erfahrener Vorstand: 3034Die Vorstandsmitglieder gelten als erfahren (9.5 Jahre durchschnittliche Amtszeit).

Qol Holdings Management

Management Kriterienprüfungen 2/4

Wichtige Informationen

Jüngste Management Updates

Qol Holdings Co., Ltd., Annual General Meeting, Jun 27, 2024

Qol Holdings Co., Ltd., Annual General Meeting, Jun 28, 2023

Qol Holdings Co., Ltd., Annual General Meeting, Jun 29, 2022

Less than half of directors are independent

Recent updates

Upcoming dividend of JP¥17.00 per share

Qol Holdings Co., Ltd. to Report Q2, 2025 Results on Nov 01, 2024

First quarter 2025 earnings released: EPS: JP¥22.58 (vs JP¥27.19 in 1Q 2024)

Estimating The Fair Value Of Qol Holdings Co., Ltd. (TSE:3034)

Investor sentiment deteriorates as stock falls 21%

Final dividend of JP¥17.00 announced

Qol Holdings Co., Ltd. to Report Q1, 2025 Results on Aug 02, 2024

Qol Holdings Co., Ltd. (TSE:3034) agreed to acquire Bottom Heart Co., Ltd./Gyotoku Pharmacy Co., Ltd.

There May Be Some Bright Spots In Qol Holdings' (TSE:3034) Earnings

Investor sentiment deteriorates as stock falls 17%

Qol Holdings Co., Ltd.'s (TSE:3034) Shares Not Telling The Full Story

Full year 2024 earnings: EPS misses analyst expectations

Qol Holdings Co., Ltd., Annual General Meeting, Jun 27, 2024

Upcoming dividend of JP¥15.00 per share

Third quarter 2024 earnings released: EPS: JP¥50.64 (vs JP¥48.42 in 3Q 2023)

Qol Holdings Co., Ltd. Provides Dividend Guidance for the Year Ending March 31, 2024

Qol Holdings Co., Ltd. to Report Q3, 2024 Results on Feb 02, 2024

Second quarter 2024 earnings released: EPS: JP¥23.60 (vs JP¥36.94 in 2Q 2023)

Upcoming dividend of JP¥15.00 per share at 1.7% yield

First quarter 2024 earnings released: EPS: JP¥27.19 (vs JP¥27.15 in 1Q 2023)

Consensus EPS estimates increase by 13%

Price target increased by 7.7% to JP¥2,800

Qol Holdings Co., Ltd. to Report Q1, 2024 Results on Aug 04, 2023

Investor sentiment improves as stock rises 16%

Qol Holdings Co., Ltd. (TSE:3034) agreed to acquire Daiichi Sankyo Espha Co., Ltd. from Daiichi Sankyo Company, Limited (TSE:4568) for ¥25 billion.

Full year 2023 earnings: EPS exceeds analyst expectations

Qol Holdings Co., Ltd., Annual General Meeting, Jun 28, 2023

Upcoming dividend of JP¥17.00 per share at 2.6% yield

Third quarter 2023 earnings released: EPS: JP¥48.42 (vs JP¥46.27 in 3Q 2022)

Qol Holdings Co., Ltd. Provides Commemorative Dividend Guidance for the Fiscal Year Ending March 31, 2023

Qol Holdings Co., Ltd. to Report Q3, 2023 Results on Feb 03, 2023

Second quarter 2023 earnings released: EPS: JP¥36.94 (vs JP¥38.75 in 2Q 2022)

Price target decreased to JP¥2,300

Second quarter 2023 earnings released: EPS: JP¥36.94 (vs JP¥38.75 in 2Q 2022)

Upcoming dividend of JP¥15.00 per share

Qol Holdings Co., Ltd. to Report Q2, 2023 Results on Nov 04, 2022

Investor sentiment deteriorated over the past week

Qol Holdings Co., Ltd. Provides Dividend Guidance for the Second Quarter and Full Year Ending of March 31, 2023

First quarter 2023 earnings released: EPS: JP¥27.15 (vs JP¥28.20 in 1Q 2022)

Qol Holdings Co., Ltd. to Report Q1, 2023 Results on Aug 05, 2022

Investor sentiment improved over the past week

Full year 2022 earnings: EPS exceeds analyst expectations

Qol Holdings Co., Ltd., Annual General Meeting, Jun 29, 2022

Price target decreased to JP¥2,050

Less than half of directors are independent

Qol Holdings Co., Ltd. to Report Fiscal Year 2022 Results on May 13, 2022

Upcoming dividend of JP¥14.00 per share

Third quarter 2022 earnings: EPS in line with expectations, revenues disappoint

Second quarter 2022 earnings released: EPS JP¥38.75 (vs JP¥10.82 in 2Q 2021)

Investor sentiment improved over the past week

Upcoming dividend of JP¥14.00 per share

First quarter 2022 earnings released: EPS JP¥28.20 (vs JP¥5.92 in 1Q 2021)

Qol Holdings Co., Ltd. (TSE:3034) acquired KI Chozai Yakkyoku Ltd.

Full year 2021 earnings released: EPS JP¥89.53 (vs JP¥107 in FY 2020)

Upcoming dividend of JP¥14.00 per share

New 90-day high: JP¥1,499

Analysts update estimates

Analysts lower EPS estimates to JP¥79.60

Third quarter 2021 earnings released: EPS JP¥41.78 (vs JP¥28.55 in 3Q 2020)

Revenue behind estimates

New 90-day high: JP¥1,178

Qol Holdings Co., Ltd. to Report Q3, 2021 Results on Feb 03, 2021

Qol Holdings Co., Ltd. (TSE:3034) acquired Katsuharaku Pharmacy Co., Ltd.

Price target lowered to JP¥1,200

Qol Holdings Co., Ltd. (TSE:3034) acquired 7 pharmacies in Ibaraki and Osaka.

Qol Holdings Co., Ltd. to Report Q1, 2021 Results on Jul 30, 2020

Geschäftsführer

Amtszeit

Führungsteam

Durchschnittliche Betriebszugehörigkeit

Durchschnittliches Alter